EZM0414 is a potent, selective, orally bioavailable inhibitor of SETD2 (IC50=18 nM in SETD2 biochemical assay, IC50=34 nM in cellular assay). EZM0414 can be used for the research of relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma[1].
Molecular Weight:
400.49
Purity:
99.11
CAS Number:
[2411748-50-8]
Formula:
C22H29FN4O2
Target:
Histone Methyltransferase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted